Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 11, 2026 · Filed Nov 12, 2026
The CEO of Tonix Pharmaceuticals paid $20K out of pocket for Tonix Pharmaceuticals shares. It was the first purchase in 18 months. Shares held went up 45% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$20,275
Shares × reported transaction price
<$25K
+45.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 18 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the CEO's reported total pay for fiscal 2025 ($2.92M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-30. The proxy names Seth Lederman as CEO for that year. A size comparison, not a judgement
2 days after results of Nov 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $3.87 on Nov 11, 2026, at its 52-week low, after a 60% drop over the previous 30 trading days
52-week range $3.87 (Nov 11, 2026) to $19.89 (Dec 8, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $9.74 on Sep 30, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any TNXP insider since Aug 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.